Silencing with precision: In silico strategies for antisense oligonucleotide engineering. [PDF]
Nagaraj A +7 more
europepmc +1 more source
Selection, validation and delivery of DNA aptamers against infectious disease targets
Joint Symposium of the 5th Annual Meeting of the Oligonucleotide Therapeutics Society and the 19th Antisense Symposium, Fukuoka, Japan, 4-5 November ...
Lin, YP +5 more
core
Peptide nucleic acid as antibacterial agents via the antisense principle
antibiotics, antisense, bacteria, oligonucleotide, peptide nucleic acid ...
Nielsen, Peter Eigil
core +1 more source
Imaging-Assisted Antisense Oligonucleotide Delivery for Tumor-Targeted Gene Therapy
Antisense oligonucleotide (ASO) represents a class of practical tools for targeting undruggable oncogenes with several candidates currently undergoing clinical investigation. The advancement of antisense therapeutics necessitates comprehensive approaches
Hanwen Liao (18396321) +6 more
core +1 more source
Tripled-Stranded Antisense Oligonucleotide for Biomarker-Activated Suppression of Essential Genes. [PDF]
Drozd VS +7 more
europepmc +1 more source
The response of the CML-BC cell line, K562, the myelomonocytic cell line MM6 and the promyelocytic leukaemia cell line HL-60, to a 15 mer WT1 antisense oligonucleotide, targeted to the translation initiation site of the WT1 mRNA was examined.
Smith, P. J. +11 more
core
Clinical Pharmacology of Eplontersen, the First Approved GalNAc-Conjugated Antisense Oligonucleotide. [PDF]
Yu RZ +4 more
europepmc +1 more source
Aptamer-mediated inhibition of sclerostin for osteoporosis therapy
Joint Symposium of the 5th Annual Meeting of the Oligonucleotide Therapeutics Society and the 19th Antisense Symposium, Fukuoka, Japan, 4-5 November ...
Leung, CM, Shum, K, Chan, C, Tanner, JA
core
Advances in antisense oligonucleotide treatment for cancer. [PDF]
Zhu L, Muhtar P, Goyama S, Yoshimi A.
europepmc +1 more source
Antisense oligonucleotide-mediated disruption of mRNA localisation inhibits angiogenesis. [PDF]
Augustine J +7 more
europepmc +1 more source

